The Stockholm Stock Exchange rose on Thursday, marking the seventh consecutive trading day of gains for the OMXS30 index.

At the close, the OMXS30 index was up 0.45 percent to 2,606.08. Shares worth around SEK 17.2 billion were traded on the Stockholm Stock Exchange.

The best performance among the stock exchange's major industrial sectors was technology with a rise of 1.62 percent. At the other end of the scale, real estate was at the bottom with minus 2.11 percent.

Among the leading stocks, which are included in the OMXS30 index, Hexagon rose 2.6 percent while SEB was up 2.5 percent. SBB B was the worst performer, down 3.7 percent, while Getinge was down 1.1 percent.

Measurement technology company Hexagon was the most traded share and rose another 2.6 percent in the wake of the announcement earlier this week that Björn Rosengren will take over as chairman from Ola Rollén at the AGM in 1.5 years.

Real estate company SBB has received additional letters from bondholders expressing their intention to request early redemption of Eurobonds under the EMTN programs. The share fell 3.7%.

AstraZeneca's Imfinizi was approved by the US Food and Drug Administration (FDA) for the treatment of adult patients with limited-stage small cell lung cancer whose disease has not progressed after concurrent platinum-based chemotherapy and radiation therapy. The stock rose 0.6%.

Steel company SSAB was awarded a total of SEK 1.45 billion in EU support by the Swedish Agency for Economic and Regional Growth to convert to fossil-free steel production. The share fell 0.8 percent.

Private equity firm EQT launched a new strategy, EQT Transition Infrastructure, and in connection with it a first acquisition, Ju:niz Energy, a German developer and operator of energy storage systems. The share rose 1.6 percent.

The largest shareholder of the optician chain Synsam, Theia Holdings, owned by private equity firm CVC Capital, sold 16 million shares at a price of SEK 41 per share. This represents a discount of 9.9 percent compared to the last closing price. The share fell by 7.7 percent.

IAR Systems raised its 3-5 year growth targets as part of the technology company's new growth strategy, where it is broadening its addressable market through technological and geographical expansion. The targets are now 20 percent growth in local currency, with an operating margin of at least 20 percent. The share rose 2.4 percent.

Research company Bioarctic's partner Eisai announced that the Mexican Medicines Agency has approved Leqembi for the treatment of early Alzheimer's disease. Bioarctic also announced that the first patient has now been dosed with exidavnemab in the phase 2a study Exist in Parkinson's disease. The stock rose 1.7 percent.

Cybersecurity company Yubico began trading on Nasdaq Stockholm after moving from First North. The share rose 3.4 percent.

Telecommunications installation company Eltel won a tender for a new contract period for maintenance and fault repair for the Swedish Transport Administration's nationwide communications network. The maximum contract period is seven years, including four option years. The total value amounts to SEK 950 million, of which the value for the initial three-year period is estimated at SEK 400 million. The share rose 1.6 percent.

SEB raised its recommendation for online broker Avanza Bank to buy from hold with a target price of SEK 287. The share climbed 2.9 percent.

Kepler Cheuvreux initiated coverage of the sludge suction company Norva24 with a buy recommendation and a target price of SEK 34. The share rose 1.2 percent.

Nordea initiated coverage of hotel real estate company Pandox with a buy recommendation and a target price of SEK 230. The share rose 1.7 percent.

HSBC raised its recommendation for engineering company SKF to buy, from previously hold. The target price is set at SEK 255. The share rose 1.4 percent.

Handelsbanken lowered its advice for Systemair both in the short and long term. The share fell by 5.5 percent.